1. Home
  2. MNOV vs FSI Comparison

MNOV vs FSI Comparison

Compare MNOV & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.40

Market Cap

66.9M

Sector

Health Care

ML Signal

HOLD

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$5.35

Market Cap

67.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNOV
FSI
Founded
2000
1991
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
66.9M
67.8M
IPO Year
2004
2000

Fundamental Metrics

Financial Performance
Metric
MNOV
FSI
Price
$1.40
$5.35
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
55.9K
14.6K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
1.86%
EPS Growth
N/A
9.09
EPS
N/A
0.09
Revenue
$2,360,807.00
$15,494,325.00
Revenue This Year
N/A
$4.11
Revenue Next Year
N/A
$58.09
P/E Ratio
N/A
$59.67
Revenue Growth
194.15
N/A
52 Week Low
$1.13
$3.46
52 Week High
$1.96
$11.48

Technical Indicators

Market Signals
Indicator
MNOV
FSI
Relative Strength Index (RSI) 46.32 49.17
Support Level $1.21 $5.21
Resistance Level $1.43 $5.47
Average True Range (ATR) 0.06 0.24
MACD -0.00 0.01
Stochastic Oscillator 24.25 43.33

Price Performance

Historical Comparison
MNOV
FSI

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

Share on Social Networks: